| P50 | author | Sakae Tanaka | Q39065998 |
| P2093 | author name string | Akira Fukuda | |
| | Kozo Nakamura | |
| | Hiromi Oda | |
| | Hirotaka Chikuda | |
| | Tsuyoshi Miyazaki | |
| | Yuho Kadono | |
| | Hisataka Yasuda | |
| | Atsuhiko Hikita | |
| | Hidetoshi Wakeyama | |
| P2860 | cites work | Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1 | Q24305944 |
| | Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1 | Q24307304 |
| | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells | Q24315251 |
| | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells | Q28119154 |
| | Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival | Q28142897 |
| | Catalytic properties of ADAM19 | Q28189426 |
| | The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor | Q28285539 |
| | A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF | Q28296638 |
| | Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification | Q28505336 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras | Q28646214 |
| | Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 |
| | Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 |
| | EGF receptor ligands | Q34185050 |
| | Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity | Q36400613 |
| | Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis | Q39124107 |
| | Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades | Q41708821 |
| | Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase | Q43559838 |
| | Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption | Q44590734 |
| P433 | issue | 50 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 41700-41706 | |
| P577 | publication date | 2005-10-18 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding | |
| P478 | volume | 280 | |